Ablynx NV ($ABLX) #IPO Preview
Company: Ablynx NV Symbol: ABLX Description: They are a late-stage clinical biopharmaceutical company utilizing our proprietary Nanobody platform to develop treatments for a broad range of therapeutic indications with an unmet medical need. Shares: 9.17 million Price Range: $19.08-$19.08 Trade Date: 10/25 Underwriter(s): BofA Merrill Lynch, J.P. Morgan, Jefferies Co-Manager(s): Baird, Bryan Garnier & Co.,[…]
